myotwin employs an innovative technology for heartdrug discovery. With a proprietary heart muscle organoid and patentedmeasurement methods, the platform delivers clinically relevant data on efficacyand toxicity. It is also able to model complex diseases like heart failure,accelerating and reducing the cost of drug development while significantlylowering animal testing.